223556-29-4 Usage
Chemical compound
1-Cyclopropylpiperazine hydrochloride is a chemical compound that is used in the synthesis of pharmaceutical drugs and research purposes.
Derivative of piperazine
It is a derivative of piperazine and contains a cyclopropyl ring.
Solubility
The hydrochloride salt form of this compound is highly soluble in water.
Administration
It can be administered orally or intravenously.
Serotonin receptor antagonist
It is known to act as an antagonist at certain serotonin receptor sites in the brain.
Potential use in treating neurological and psychiatric disorders
It has been studied for its potential use in treating neurological and psychiatric disorders.
Building block in the synthesis of other organic compounds
1-Cyclopropylpiperazine hydrochloride may also be used as a building block in the synthesis of other organic compounds for various applications in the pharmaceutical and chemical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 223556-29-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,3,5,5 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 223556-29:
(8*2)+(7*2)+(6*3)+(5*5)+(4*5)+(3*6)+(2*2)+(1*9)=124
124 % 10 = 4
So 223556-29-4 is a valid CAS Registry Number.
223556-29-4Relevant articles and documents
AMINOPYRIMIDINE HETEROCYCLIC COMPOUND WITH ADENOSINE RECEPTOR ANTAGONISTIC ACTIVITY
-
Paragraph 000101; 000104; 000105, (2017/06/23)
Disclosed hereinis an aminopyrimidine heterocyclic compound with adenosine receptor antagonistic activity, comprising a compound of the general formula (I), or a pharmaceutically acceptable salt thereof. The aminopyrimidine heterocyclic compound with adenosine receptor antagonistic activitydisclosed herein can be used as an effective adenosine receptor antagonist, and can be used for the treatment or prevention of disorders caused by abnormal level of adenosine.
FIVE-MEMBERED HETEROCYCLIC DERIVATIVE
-
Page/Page column 48, (2010/11/08)
The present invention relates to a compound represented by formula (I): a salt of the compound, or a solvate of the compound or the salt; a drug containing any of the compounds, the salts, and the solvates; a preventive and/or therapeutic agent for an ischemic disease containing any of the compounds, the salts, and the solvates; and a platelet coagulation inhibitor containing any of the compounds, the salts, and the solvates. The compound of the present invention is useful as a strong platelet coagulation inhibitor without inhibiting COX-1 or COX-2.
